Business · National
Novo’s Home Country Pays 31 Obesity Drug Users for Eye Condition
Denmark has granted 15 million kroner ($2.2 million) in compensation to 31 people who developed a rare but serious eye condition after using Novo Nordisk A/S’s weight-loss medicines as the safety issue grows in the drugmaker’s home country.
Verified Timeline
No verified timeline updates.
What is your view on “Novo’s Home Country Pays 31 Obesity Drug Users for Eye Condition”?
This is self-selected reader participation, not representative scientific polling.

